Chimeric Antigen Receptor (CAR) Regulatory T-Cells in Solid Organ Transplantation
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chimeric Antigen Receptor (CAR) Regulatory T-Cells in Solid Organ Transplantation
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-06-03
DOI
10.3389/fimmu.2022.874157
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Comprehensive Evaluation of the Antibody-Verified Status of Eplets Listed in the HLA Epitope Registry
- (2022) Suzanne Bezstarosti et al. Frontiers in Immunology
- Autologous bone marrow derived mesenchymal stromal cell therapy with early tacrolimus withdrawal: The randomized prospective, single‐center, open‐label TRITON study
- (2021) Marlies E.J. Reinders et al. AMERICAN JOURNAL OF TRANSPLANTATION
- CAR- and TRuC-redirected regulatory T cells differ in capacity to control adaptive immunity to FVIII
- (2021) Jyoti Rana et al. MOLECULAR THERAPY
- Chimeric antigen receptor‐modified human regulatory T cells that constitutively express IL‐10 maintain their phenotype and are potently suppressive
- (2021) Yasmin R. Mohseni et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Precision Engineering of an Anti-HLA-A2 Chimeric Antigen Receptor in Regulatory T Cells for Transplant Immune Tolerance
- (2021) Yannick D. Muller et al. Frontiers in Immunology
- Antigen Specific Regulatory T Cells in Kidney Transplantation and Other Tolerance Settings
- (2021) Min Hu et al. Frontiers in Immunology
- Implementation of molecular matching in transplantation requires further characterization of both immunogenicity and antigenicity of individual HLA epitopes
- (2021) Suzanne Bezstarosti et al. HUMAN IMMUNOLOGY
- CD8+ T Cells Expressing an HLA-DR1 Chimeric Antigen Receptor Target Autoimmune CD4+ T Cells in an Antigen-Specific Manner and Inhibit the Development of Autoimmune Arthritis
- (2021) Karen B. Whittington et al. JOURNAL OF IMMUNOLOGY
- Heterologous Immunity of Virus-Specific T Cells Leading to Alloreactivity: Possible Implications for Solid Organ Transplantation
- (2021) Gonca E. Karahan et al. Viruses-Basel
- Donor‐specific chimeric antigen receptor Tregs limit rejection in naive but not sensitized allograft recipients
- (2020) Antoine Sicard et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Toward an Optimized Process for Clinical Manufacturing of CAR-Treg Cell Therapy
- (2020) Enrico Fritsche et al. TRENDS IN BIOTECHNOLOGY
- Generation and reactivity analysis of human recombinant monoclonal antibodies directed against epitopes on HLA‐DR
- (2020) Cynthia S. M. Kramer et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials
- (2020) Birgit Sawitzki et al. LANCET
- Suppression of FVIII-Specific Memory B Cells by Chimeric BAR Receptor-Engineered Natural Regulatory T Cells
- (2020) Alessandra De Paula Pohl et al. Frontiers in Immunology
- CD19-targeted CAR regulatory T cells suppress B cell pathology without GvHD
- (2020) Yuki Imura et al. JCI Insight
- Functional effects of chimeric antigen receptor co-receptor signaling domains in human regulatory T cells
- (2020) Nicholas A. J. Dawson et al. Science Translational Medicine
- Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial
- (2020) Andy Roemhild et al. BMJ-British Medical Journal
- Engineered regulatory T cells expressing myelin-specific chimeric antigen receptors suppress EAE progression
- (2020) Alessandra De Paula Pohl et al. CELLULAR IMMUNOLOGY
- Antigen Specificity Enhances Disease Control by Tregs in Vitiligo
- (2020) Zhussipbek Mukhatayev et al. Frontiers in Immunology
- Feasibility, long‐term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients
- (2020) Paul N. Harden et al. AMERICAN JOURNAL OF TRANSPLANTATION
- HLA-A*02:01-directed chimeric antigen receptor/forkhead box P3-engineered CD4+ T cells adopt a regulatory phenotype and suppress established graft-versus-host disease
- (2020) Aaron Martin et al. CYTOTHERAPY
- Mechanisms of resistance to CAR T cell therapy
- (2019) Nirali N. Shah et al. Nature Reviews Clinical Oncology
- IL‐2 therapy preferentially expands adoptively transferred donor‐specific Tregs improving skin allograft survival
- (2019) Kulachelvy Ratnasothy et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes
- (2019) Michel Tenspolde et al. JOURNAL OF AUTOIMMUNITY
- Transplantation in highly sensitized patients: challenges and recommendations
- (2018) Sebastiaan Heidt et al. Expert Review of Clinical Immunology
- Tolerance in clinical liver transplantation
- (2018) Josh Levitsky et al. HUMAN IMMUNOLOGY
- Retroviral and Lentiviral Safety Analysis of Gene-Modified T Cell Products and Infused HIV and Oncology Patients
- (2018) Katherine T. Marcucci et al. MOLECULAR THERAPY
- Ex Vivo Expanded Human Non-Cytotoxic CD8+CD45RClow/− Tregs Efficiently Delay Skin Graft Rejection and GVHD in Humanized Mice
- (2018) Séverine Bézie et al. Frontiers in Immunology
- Epigenetic mechanisms regulating T-cell responses
- (2018) Christian Schmidl et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Strategies to Address Chimeric Antigen Receptor Tonic Signaling
- (2018) Adam Ajina et al. MOLECULAR CANCER THERAPEUTICS
- Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
- (2017) Justin Eyquem et al. NATURE
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL-2 therapy restores regulatory T-cell dysfunction induced by calcineurin inhibitors
- (2017) Gavin Whitehouse et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD45RA Distinguishes CD4+CD25+CD127−/low TSDR Demethylated Regulatory T Cell Subpopulations With Differential Stability and Susceptibility to Tacrolimus-Mediated Inhibition of Suppression
- (2017) Rebeca Arroyo Hornero et al. TRANSPLANTATION
- Augmentation of Antitumor Immunity by Human and Mouse CAR T Cells Secreting IL-18
- (2017) Biliang Hu et al. Cell Reports
- Chimeric Antigen Receptor-Redirected Regulatory T Cells Suppress Experimental Allergic Airway Inflammation, a Model of Asthma
- (2017) Jelena Skuljec et al. Frontiers in Immunology
- Targeted antibody-mediated depletion of murine CD19 CAR T cells permanently reverses B cell aplasia
- (2016) Paulina J. Paszkiewicz et al. JOURNAL OF CLINICAL INVESTIGATION
- Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor
- (2016) Katherine G. MacDonald et al. JOURNAL OF CLINICAL INVESTIGATION
- CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia
- (2015) S. L. Maude et al. BLOOD
- Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantation
- (2015) X. Zhou et al. BLOOD
- Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect
- (2015) C. G. Brunstein et al. BLOOD
- 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors
- (2015) Adrienne H Long et al. NATURE MEDICINE
- Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T Cells
- (2015) M. J. Frigault et al. Cancer Immunology Research
- A highly compact epitope-based marker/suicide gene for easier and safer T-cell therapy
- (2014) B. Philip et al. BLOOD
- A Novel Chimeric Antigen Receptor Against Prostate Stem Cell Antigen Mediates Tumor Destruction in a Humanized Mouse Model of Pancreatic Cancer
- (2014) Daniel Abate-Daga et al. HUMAN GENE THERAPY
- Of CARs and TRUCKs: chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma
- (2013) Markus Chmielewski et al. IMMUNOLOGICAL REVIEWS
- Arming Cytokine-induced Killer Cells With Chimeric Antigen Receptors: CD28 Outperforms Combined CD28–OX40 “Super-stimulation”
- (2013) Andreas A Hombach et al. MOLECULAR THERAPY
- Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning
- (2012) H. J. Pegram et al. BLOOD
- HLA-A, -B, -DR allele group frequencies in 7007 kidney transplant list patients in 27 UK centres
- (2012) C. Burt et al. International Journal of Immunogenetics
- CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery
- (2012) Moa Fransson et al. Journal of Neuroinflammation
- A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells
- (2011) X. Wang et al. BLOOD
- Requirements for Prolongation of Allograft Survival with Regulatory T Cell Infusion in Lymphosufficient Hosts
- (2011) Todd V. Brennan et al. JOURNAL OF SURGICAL RESEARCH
- Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy
- (2011) Antonio Di Stasi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human Regulatory T Cells with Alloantigen Specificity Are More Potent Inhibitors of Alloimmune Skin Graft Damage than Polyclonal Regulatory T Cells
- (2011) P. Sagoo et al. Science Translational Medicine
- Differential Role of Naïve and Memory CD4+ T-Cell Subsets in Primary Alloresponses
- (2010) D. Golshayan et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Allo-HLA reactivity of virus-specific memory T cells is common
- (2010) A. L. Amir et al. BLOOD
- Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans
- (2010) Pervinder Sagoo et al. JOURNAL OF CLINICAL INVESTIGATION
- Identification of a B cell signature associated with renal transplant tolerance in humans
- (2010) Kenneth A. Newell et al. JOURNAL OF CLINICAL INVESTIGATION
- Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety
- (2010) V Hoyos et al. LEUKEMIA
- In vivo prevention of transplant arteriosclerosis by ex vivo–expanded human regulatory T cells
- (2010) Satish N Nadig et al. NATURE MEDICINE
- Contribution of Naïve and Memory T-Cell Populations to the Human Alloimmune Response
- (2009) C. Macedo et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Calcineurin Inhibitor Minimization in the Symphony Study: Observational Results 3 Years after Transplantation
- (2009) H. Ekberg et al. AMERICAN JOURNAL OF TRANSPLANTATION
- First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127− T regulatory cells
- (2009) Piotr Trzonkowski et al. CLINICAL IMMUNOLOGY
- Regulatory T Cells Sequentially Migrate from Inflamed Tissues to Draining Lymph Nodes to Suppress the Alloimmune Response
- (2009) Nan Zhang et al. IMMUNITY
- Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
- (2009) Makoto Miyara et al. IMMUNITY
- Human monoclonal HLA antibodies reveal interspecies crossreactive swine MHC class I epitopes relevant for xenotransplantation
- (2009) Arend Mulder et al. MOLECULAR IMMUNOLOGY
- Regulatory T Cells and Immune Tolerance
- (2008) Shimon Sakaguchi et al. CELL
- Redirection of Regulatory T Cells With Predetermined Specificity for the Treatment of Experimental Colitis in Mice
- (2008) Eran Elinav et al. GASTROENTEROLOGY
- Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice
- (2008) Julia Yuen-Shan Tsang et al. JOURNAL OF CLINICAL INVESTIGATION
- HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression
- (2008) Tatsuo Kawai et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started